American Society Of Health – System Pharmacists issued the following announcement on Jul 22.
“Given the current COVID-19 surge and the FDA’s recent authorization of pharmacists as prescribers of Paxlovid, it is critical that pharmacists are able to begin offering this service as soon as possible.” –Tom Kraus, ASHP Vice President of Government Relations
ASHP urged CMS to clarify the mechanisms that would allow pharmacists to be reimbursed for prescribing Paxlovid and performing the clinical services needed for safe use of the product. Details: https://go.ashp.org/3PugLB3
Original source can be found here
Alerts Sign-up